Trials / Completed
CompletedNCT03471234
Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE
LATIn American sTUdy to Investigate the Clinical Performance of Sirolimus-eluting Stent With Abluminal-only bioDEgradable Polymeric Coating (Inspiron TM) in the Treatment of Native Coronary Artery Lesions.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 299 (actual)
- Sponsor
- Scitech Produtos Medicos SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, single arm registry to monitor post-market clinical outcomes of patients treated with Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer.
Detailed description
Prospective, multicenter, single arm registry to assess the safety and performance of Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer for the treatment of "real world" patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Angioplasty | Inspiron Drug Eluting stent implantation |
Timeline
- Start date
- 2018-09-03
- Primary completion
- 2020-10-30
- Completion
- 2022-08-02
- First posted
- 2018-03-20
- Last updated
- 2023-05-18
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03471234. Inclusion in this directory is not an endorsement.